Closing Bell: Fennec Pharmaceuticals Inc up on Friday (FRX)

In today's trading, Fennec Pharmaceuticals Inc stock opened at $9.20 and closed at $9.23. Intraday prices ranged from a low of $9.20 to a high of $9.23.

Shares raised 1.65 percent from the previous day's close of $9.08.

During the day across North America, the TSX Composite closed 0.91% at 22814.81, the S&P 500 closed -0.51% at 5399.22, the Dow Jones Industrial Average closed 0.20% at 39935.07 and the Nasdaq Composite closed -0.93% at 17181.72.

Fennec Pharmaceuticals Inc has listed on the Toronto Stock Exchange (TSX) under the ticker FRX.

A total of 1,101 shares was traded during the session, with total trades of 10, while having an average volume of 1,085 in the last five days.

Trading across the entire TSX saw 3,857 price advancers against 1,325 declines and 128 unchanged.

During the prior 52 weeks, FRX.TO has traded as high as $15.43 (December 28,2023) and low as $7.80 (July 05,2024). Moreover, in the last 12 months, Fennec Pharmaceuticals Inc's shares have dipped -18.10%, while they have reduced -39.12% this year.

Following today's trading, Fennec Pharmaceuticals Inc has a market capitalization of $248.09 million on a float of 27,322 shares outstanding. Its annual EPS is $0.04.

Fennec Pharmaceuticals Inc is a TSX Biotechnology company headquartered in Research Triangle Park, USA.

Fennec Pharmaceuticals Inc's average recommendation is "Strong Buy" based on 6.00 analysts according to Zacks. Currently, there are 6 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..